Raymond James Financial’s GoodRx Holdings GDRX Stock Holding History

Raymond James Financial’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$159K	Sell	55,356 -86,244	-61%	-$219K	﹤0.01%	5095
2026 Q1	$278K	Buy	141,600 +16,735	+13%	+$39.3K	﹤0.01%	4699
2025 Q4	$338K	Sell	124,865 -183,876	-60%	-$604K	﹤0.01%	4495
2025 Q3	$1.31M	Sell	308,741 -443,234	-59%	-$1.95M	﹤0.01%	3509
2025 Q2	$3.74M	Sell	751,975 -78,975	-10%	-$343K	﹤0.01%	2575
2025 Q1	$3.66M	Buy	830,950 +293,420	+55%	+$1.38M	﹤0.01%	2536
2024 Q4	$2.5M	Buy	+537,530	New	+$2.95M	﹤0.01%	2812

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Raymond James Financial's GDRX Position: Q2 2026 in Review

Raymond James Financial reduced its GoodRx Holdings (GDRX) stake by 61% in Q2 2026, selling an estimated $219K and leaving 55,356 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #5095.

Raymond James Financial first reported a position in GDRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.74M in Q2 2025. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

Raymond James Financial held 55,356 shares of GoodRx Holdings worth $159K as of Q2 2026.
Raymond James Financial sold 86,244 GoodRx Holdings shares in Q2 2026, an estimated $219K.
GoodRx Holdings made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5095 holding.
Raymond James Financial first reported a position in GoodRx Holdings in Q4 2024 and has held it in 7 quarters since.
Raymond James Financial's GoodRx Holdings position peaked at $3.74M in Q2 2025.
162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.